Fabricated data - should we quarantine? A novel tool for risk assessment is proposed
- PMID: 32307205
- PMCID: PMC7194586
- DOI: 10.1016/j.ejogrb.2020.04.020
Fabricated data - should we quarantine? A novel tool for risk assessment is proposed
Keywords: Fabricated data; Fraudulent data; Quarantine; Risk assessment tool.
References
-
- Bordewijk E.M., Wang R., Askie L.M., Gurrin L.C., Thornton J.G., van Wely M., et al. Data integrity of 35 randomised controlled trials in women’ health. Eur J Obstet Gynecol Reprod Biol. 2020;249:72–83. - PubMed
-
- Carlisle J.B., Loadsman J.A. Evidence for non-random sampling in randomised, controlled trials by Yuhji Saitoh. Anaesthesia. 2017;72(1):17–27. - PubMed
-
- Shehata N.A.A. Retraction notice to: “Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial” [Eur J Obstet Gynecol Reprod Biol (2016) 100–104] Eur J Obstet Gynecol Reprod Biol. 2019;240:387. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources